Article
US FDA declines to approve AbbVie's Parkinson's disease therapy
Rating:
0.0
Views:
47
Likes:
1
Library:
1
AbbVie Inc said on Wednesday the U.S. Food and Drug Administration had declined to approve its Parkinson's disease therapy for adults and had requested for more information on the device used to administer the treatment.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value